Researchers from the Czech Republic found that an AI system showed higher sensitivity and specificity for screening diabetic retinopathy compared to telemedicine evaluations. Researchers from the ...

The company stated that the FDA noted at least 1 additional adequate and well-controlled study to demonstrate a positive effect on the treatment of ocular symptoms of dry eye should be conducted.

This database could enhance the workflow of eye care professionals with its in-depth reference data for retinal layer thickness and optic nerve head metrics. The reference database from Optos PLC that ...

A study on the effects of methylphenidate in children with ADHD found that treated children had lower corneal endothelial cell counts compared to untreated children and a control group. A study of the ...

In the month of March, not only did trials progress, but approvals for new and expanded uses of treatments were issued. With companies around the globe working to development new candidates for ...

The ZAP-X system is described by researchers as a "dedicated, self-contained, and self-shielded surgical robot" designed for performing stereotactic surgery (SRS) on the brain, head, and neck. This ...

The results of a recent study 1 emphasized the importance of early recognition of the ocular signs of multiple myeloma because early diagnosis and treatment may have a positive impact on the disease ...

One intravitreal injection of the dexamethasone implant in patients with refractory DME induced significant anatomic and functional improvements, but these improvements only lasted for short periods ...

Rebecca Silverman, MD, and associates advised evaluating the cerebrospinal fluid (CSF) in patients suspected of having vitreoretinal lymphoma to ensure that vitreoretinal lymphoma is not missed. 1 She ...

UBX1325 is a novel BCL-xL inhibitor designed to eliminate senescent cells in diabetic retinal blood vessels, while leaving healthy ones intact. After review by the Data and Safety Monitoring Board, ...

This follows successful Phase 1 results, which demonstrated a favorable safety profile for BI 771716 across both single and multiple intravitreal doses. The company also reported a positive outcome of ...